Skip to content

Thursday, November 21, 2024

Latest:

FROM THE LABS: From bench to bedside: Osteoarthritis gene therapy developed in the lab at Baylor is in clinical trials nationwide
The dangers of vaping
Thanksgiving nutrition: enjoying holiday favorites while staying on track with your health goals
How tau becomes a ‘bad guy’ that contributes to Alzheimer’s disease
Diabetes and depression: Is there a connection between them?

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

pediatric liver cancer

Novel combination therapy offers promising results for treatment-refractory hepatoblastoma

February 20, 2024 Chemotherapy, HDAC, hepatoblastoma, panobinostat, pediatric liver cancer, Research

Hepatoblastoma (HB) is the most common liver cancer in children. Researchers and physicians in the field are concerned because in the last decade HB has

Molecular profiling identifies new high-risk subtype of pediatric liver cancer

May 24, 2022 cancer treatment, diagnostic algorithm for cancer, hepatoblastoma, hepatocellular carcinoma, molecular profiling, pediatric liver cancer, Research

The findings support a diagnostic algorithm to identify the cancer subtype and guide specialized treatment.

From the Labs: Image of the Month

From the Labs: Aging signs.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951